Vulnerability Description
LRM does not implement authentication or authorization by default. A malicious actor can inject, replay, modify, and/or intercept sensitive data.
CVSS Score
CRITICAL
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Illumina | Local Run Manager | >= 1.3, <= 3.1 |
| Illumina | Iseq 100 | - |
| Illumina | Miniseq | - |
| Illumina | Miseq | - |
| Illumina | Miseq Dx | - |
| Illumina | Nextseq 500 | - |
| Illumina | Nextseq 550 | - |
| Illumina | Nextseq 550Dx | - |
Related Weaknesses (CWE)
References
- https://www.cisa.gov/uscert/ics/advisories/icsa-22-153-02Third Party AdvisoryUS Government Resource
- https://www.cisa.gov/uscert/ics/advisories/icsa-22-153-02Third Party AdvisoryUS Government Resource
FAQ
What is CVE-2022-1521?
CVE-2022-1521 is a vulnerability with a CVSS score of 9.1 (CRITICAL). LRM does not implement authentication or authorization by default. A malicious actor can inject, replay, modify, and/or intercept sensitive data.
How severe is CVE-2022-1521?
CVE-2022-1521 has been rated CRITICAL with a CVSS base score of 9.1/10. This is considered a critical vulnerability requiring immediate attention.
Is there a patch for CVE-2022-1521?
Check the references section above for vendor advisories and patch information. Affected products include: Illumina Local Run Manager, Illumina Iseq 100, Illumina Miniseq, Illumina Miseq, Illumina Miseq Dx.